Company · founded 2012
Shuttle Pharmaceuticals (United States)
Rockville, United States · shuttlepharma.com
- Citations, last 5 years
- 56
- Works, last 5 years
- 11
- h-index
- 7
- Scientists listed
- 1
- Grants since 2016
- 4
Grants received
2019–2021 · contract · N44
TOPIC 345: PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS
Anatoly Dritschilo · Shuttle Pharmaceuticals (United States) · funded by National Institutes of Health
2018–2020 · contract · N01
IGF::OT::IGF Topic 352: Cell-Based Models for Prostate Cancer Health Disparity Research - Moonshot Project (Phase II)
Scott Grindrod · Shuttle Pharmaceuticals (United States) · funded by National Institutes of Health
2016–2017 · contract · N43
IGF::OT::IGF PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS
Phd Grindrod · Shuttle Pharmaceuticals (United States) · funded by National Institutes of Health
2016–2017 · contract · N43
IGF::OT::IGF SBIR PHASE I TOPIC 352 CELL-BASED MODELS FOR PROSTATE CANCER HEALTH DISPARITY RESEARCH
Johng Rhim · Shuttle Pharmaceuticals (United States) · funded by National Institutes of Health
